Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model

BMC Neurosci. 2010 Apr 30:11:57. doi: 10.1186/1471-2202-11-57.

Abstract

Background: Overexpression and abnormal accumulation of aggregated alpha-synuclein (alphaS) have been linked to Parkinson's disease (PD) and other synucleinopathies. alphaS can misfold and adopt a variety of morphologies but recent studies implicate oligomeric forms as the most cytotoxic species. Both genetic mutations and chronic exposure to neurotoxins increase alphaS aggregation and intracellular reactive oxygen species (ROS), leading to mitochondrial dysfunction and oxidative damage in PD cell models.

Results: Here we show that curcumin can alleviate alphaS-induced toxicity, reduce ROS levels and protect cells against apoptosis. We also show that both intracellular overexpression of alphaS and extracellular addition of oligomeric alphaS increase ROS which induces apoptosis, suggesting that aggregated alphaS may induce similar toxic effects whether it is generated intra- or extracellulary.

Conclusions: Since curcumin is a natural food pigment that can cross the blood brain barrier and has widespread medicinal uses, it has potential therapeutic value for treating PD and other neurodegenerative disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Apoptosis / physiology
  • Cell Line, Tumor
  • Curcumin / pharmacology*
  • Curcumin / therapeutic use
  • Humans
  • Models, Biological
  • Neurons / drug effects
  • Neurons / metabolism
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Neurotoxins / antagonists & inhibitors*
  • Neurotoxins / metabolism
  • Neurotoxins / toxicity
  • Oxidative Stress / drug effects*
  • Oxidative Stress / physiology
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / metabolism
  • Parkinson Disease / physiopathology
  • Reactive Oxygen Species / antagonists & inhibitors
  • Reactive Oxygen Species / metabolism
  • Substantia Nigra / drug effects
  • Substantia Nigra / metabolism
  • Substantia Nigra / physiopathology
  • alpha-Synuclein / antagonists & inhibitors*
  • alpha-Synuclein / metabolism
  • alpha-Synuclein / toxicity

Substances

  • Neuroprotective Agents
  • Neurotoxins
  • Reactive Oxygen Species
  • alpha-Synuclein
  • Curcumin